S&P 500
(-0.60%) 5 235.48 points

Dow Jones
(-0.86%) 38 111 points

Nasdaq
(-1.08%) 16 737 points

Oil
(0.00%) $77.91

Gas
(0.00%) $2.57

Gold
(0.06%) $2 367.90

Silver
(-0.84%) $31.27

Platinum
(0.00%) $1 038.00

USD/EUR
(0.14%) $0.924

USD/NOK
(0.14%) $10.55

USD/GBP
(0.07%) $0.786

USD/RUB
(0.00%) $90.27

Realtime updates for Protalix Biotherapeutics [PLX]

Exchange: AMEX Sector: Healthcare Industry: Biotechnology

Last Updated30 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

1.79% $ 1.140

Live Chart Being Loaded With Signals

Commentary (30 May 2024 @ 16:00):

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally...

Stats
Today's Volume	252 155
Average Volume	433 259
Market Cap	83.58M
EPS	$0 ( 2024-05-10 )
Next earnings date	( $0.0200 ) 2024-08-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	14.25
ATR14	$0.00500 (0.44%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Bashan Dror	Buy	263 960	Common Stock
2023-10-19	Bashan Dror	Buy	16 129	Common Stock
2023-10-19	Bashan Dror	Buy	48 387	Common Stock
2023-09-29	Boudes Pol F	Buy	61 676	Stock Options (Right to Buy)
2023-09-29	Melincoff Gwen A	Buy	61 676	Stock Options (Right to Buy)

INSIDER POWER
100.00
Last 87 transactions
Buy: 22 496 164 \| Sell: 34 117 800

Volume Correlation

Long: -0.34 (neutral)

Short: -0.96 (very strong negative)

Signal:(35.187) Neutral

Protalix Biotherapeutics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Protalix Biotherapeutics Correlation - Currency/Commodity

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.18
( neutral )

0.28
( neutral )

Protalix Biotherapeutics Financials

Annual	2023
Revenue:	$65.49M
Gross Profit:	$42.51M (64.91 %)
EPS:	$0.120

FY	2023
Revenue:	$65.49M
Gross Profit:	$42.51M (64.91 %)
EPS:	$0.120

FY	2022
Revenue:	$47.64M
Gross Profit:	$28.05M (58.87 %)
EPS:	$-0.310

FY	2021
Revenue:	$38.35M
Gross Profit:	$22.00M (57.37 %)
EPS:	$-0.620

Financial Reports:

No articles found.

Protalix Biotherapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Protalix Biotherapeutics

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.